Search

everythinglearnresearchcommunity

for

Search:↓

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Women with PCOS often feel stigmatized and have mood issues, which can lower their sexual satisfaction, but proper treatment and support can help.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Alopecia common in teens, may indicate endocrine issue, minoxidil effective treatment.

Early detection and treatment of PCOS in teenagers is important to manage symptoms and prevent severe issues.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Melatonin improved mental health and metabolism in women with PCOS.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Women with PCOS have lower ghrelin levels and a weaker response to sugar, which might affect their feeling of fullness and lead to overeating.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Metformin taken during pregnancy increases SHBG in newborns but doesn't change other hormone levels in mothers or babies.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.